CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in genome and enzymology research work in the field of disease diagnostics
4.1.2. Growing healthcare expenditure
4.1.3. Increasing government funding and investments in research and development
4.1.4. Increase in adoption of bioengineering techniques
4.1.5. Rise in technological advancements in the market
4.2. Market Restraints & Challenges
4.2.1. Lack of trained professionals
4.2.2. Increasing competition in the protein labeling market
4.3. Market Opportunities
4.3.1. Emerging economies
4.3.2. Greater potency with reduced costs and increasing affordability
CHAPTER 5 GLOBAL PROTEIN LABELING MARKET – BY LABELING METHOD
5.1. In vitro labeling
5.1.1. Nanoparticle labeling
5.1.2. Site-specific Labeling
5.1.3. Dye-based
5.1.4. Co-translational labeling
5.1.5. Enzymatic Labeling
5.2. In vivo labeling
5.2.1. Radioactive Labeling
5.2.2. Photoreactive Labeling
5.3. Biorthogonal labeling
CHAPTER 6 GLOBAL PROTEIN LABELING MARKET – BY PRODUCT
6.1. Reagents
6.1.1. Enzymes
6.1.2. Monoclonal Antibodies
6.1.3. Probes/Tags
6.1.4. Protein
6.2. Kits
6.3. Services
CHAPTER 7 GLOBAL PROTEIN LABELING MARKET – BY APPLICATION
7.1. Cell-based Assays
7.2. Fluorescence Microscopy
7.3. Immunological Techniques
7.4. Mass Spectrometry
7.5. Protein Microarray
CHAPTER 8 GLOBAL PROTEIN LABELING MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL PROTEIN LABELING MARKET - COMPANY PROFILES
9.1. Kaneka Corporation
9.2. Thermo Fisher Scientific, Inc.
9.3. Merck Millipore
9.4. Promega Corporation
9.5. F. Hoffmann-La Roche AG
9.6. New England Biolabs
9.7. LI-COR, Inc.
9.8. Sera Care Lifesciences, Inc.
9.9. GE Healthcare
9.10. PerkinElmer, Inc.
9.11. Qiagen N.V.
9.12. Active Motif, Inc.
9.13. Takara Bio USA, Inc.
9.14. Candor Bioscience GMBH
9.15. Innova Biosciences Ltd.
9.16. Luminex Corporation
CHAPTER 10 GLOBAL PROTEIN LABELING MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
